medigraphic.com
ISSN 0016-3813 (Print)

2001, Number 5

<< Back Next >>

Gac Med Mex 2001; 137 (5)

Tesselated Fundus as a Protective Factor in the Development of Diabetic Retinopathy.

Lima-Gómez V, Rojas-Dosal JA, León-Rivera N

Language: Spanish
References: 22
Page: 413-418
PDF size: 39.84 Kb.


ABSTRACT

Objective: To identify whether tessellated fundus unrelated to myopia modifies the rate of diabetic patients with retinopathy. Method: Diabetic patients evaluated ophthalmo-scopically for the first time from September 1998 to December 1999 were retrospectively reviewed, and the presence of diabetic retinopathy was compared with those with tessellated fundus (group 1) and without (group 2). Duration of diabetes and presence of retinopathy were evaluated. Differences were analysed with x2. Results: 621 patients were evaluated, 138 of whom (22%) had tessellated fundus. The rate of patients with diabetic retinopathy was statistically lower in group 1 than in group 2 (p = 0.00); this difference was maintained after correction for cumulated diabetes duration. Discussion: The presence of tessellated fundus was associated with a lower rate of patients with diabetic retinopathy and with delayed onset. Manifestations of diabetic retinopathy in patients with tessellated fundus might have a different expression, and this expression might not necessarily reflect the microvascular status of the patient.


REFERENCES

  1. Moss SE, Klein R, Klein BE. The 14 year incidence of visual loss in a diabetic population. Ophthalmology 1998;106:998-1003.

  2. Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 1998:105;1801-1815.

  3. Becker B. Diabetes and glaucoma. En: Vascular complications of diabetes mellitus. Kumira SJ, Caygill WM (Eds.). Mosby-Year-Book St. Louis 1967, PP 43-48.

  4. Weiter JJ, Zuckermann R. The influence of the photoreceptor-RPE complex on the inner retina: an explanation for the beneficial effects of photocoagulation. Ophthalmology 1980;87:1133-1139.

  5. Jain IS, Luthra CL Das T. Diabetic retinopathy and its relation to errors of refraction. Arch Ophthalmol 1967;77:59-60.

  6. Rand LI, Krolewski AS, AieIIo LM, Warram JH, Baker RS, Maki T. Multiple factors in the prediction of risk of proliferative diabetic retinopathy. N Engl J Med 1985;313:1433-1438.

  7. Dogru M, Inoue M, Nakamura M, Yamamoto M. Modifying factors related to asymmetric diabetic retinopathy. Eye 1998;12(Pt 6):929-933.

  8. Quigley M, Cohen S. A new pressure attenuation index to evaluate retinal circulation. A link to protective factors in diabetic retinopathy. Arch Ophthalmol 1999 Jan; 17:84-89.

  9. Malinowski SM, Pulido JS, Flickinger RR. The protective effect of the tilted disc syndrome in diabetic retinopathy. Arch Ophthalmol 1996 Feb;114:230-231.

  10. Moss SE, Klein R, KIein BE. Ocular factors in the incidence and progression of diabetic retinopathy. Ophthalmology 1994 Jan;101:77-83.

  11. Baker RS, Rand LI, Krolewski AS, Maki T, Warram JH, Aiello LM. Influence of HLA-DR phenotype and myopia on the risk of nonproliferative and proliferative diabetic retinopathy. Am J Ophthalmol 1986;102:693-700.

  12. Pierro L, Brancato R, Robino X, Lattanzio R, Jansen A, Calon G. Axial length in patients with diabetes. Retina 1999;19:401-4.

  13. Noble KG, Carr RE. Pathologic myopia. Ophthalmology 1982;89:1099.

  14. Ryan SJ. (Ed). Retina. The CV Mosby Co St. Louis, 1994.

  15. Asociación Mexicana de Retina. Herrera CP (Ed). Retina y Vítreo. JHG Editores, México, 2000:170.

  16. Lima GV, Rojas DJA. Estrategia de detección masiva de retinopatía diabética. El día “D” en el Hospital Juárez de México. Cir Ciruj; 2000;68:63-66.

  17. American Academy of Ophthalmology. Basic and clinical science course. Sectionl2. Retina and Vitreous. American Academy of Ophthalmology. San Francisco, 1997:72-80.

  18. The Expert Committee on Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-97.

  19. Sánchez Corona JF, García-Cruz D, Bravo-Cuellar A. Genética de la diabetes mellitus. En: Diabetes Mellitus. Islas-Andrade S, Lifshitz-Guinzberg A. McGraw-Hill Interamericana, 2da. edición México, 1999, PP. 41 -58.

  20. Apple DJ, Rabb MF. Ocular Pathology. Mosby-YearBook, St. Louis, 1998. PP 375.

  21. Chávez-Negrete A, Chong-Martínez B. Hemorreología y diabetes mellitus. En: Diabetes Mellitus. Islas-Andrade S, Lifshitz-Guinzberg A. McGraw-Hill, Interamericana, México, 1999, PP. 163-172.

  22. Aguilar-Salinas CA, Gómez-Pérez FJ, RulL JA. Limitaciones de los criterios de diagnóstico de la diabetes tipo 2 y la intolerancia a la glucosa. Rev lnvest Clin 2000; 52:177-184.




2020     |     www.medigraphic.com